Skip to main content
Bavarian Nordic logo

Bavarian Nordic — Investor Relations & Filings

Ticker · BAVA ISIN · DK0015998017 LEI · 2138006JCDVYIN6INP51 CO Manufacturing
Filings indexed 2,297 across all filing types
Latest filing 2025-10-13 M&A Activity
Country DK Denmark
Listing CO BAVA

About Bavarian Nordic

https://www.bavarian-nordic.com/

Bavarian Nordic is a fully integrated biotechnology company specializing in the research, development, manufacturing, and commercialization of life-saving vaccines. The company's portfolio targets infectious diseases, including vaccines for Mpox, rabies, and typhoid. It is a leading global provider of travel vaccines and serves as a key partner for governments and international organizations in addressing public health preparedness needs.

Recent filings

Filing Released Lang Actions
M&A Activity 2025
M&A Activity Classification · 100% confidence The document is a formal announcement from Bavarian Nordic regarding the expiry of an offer period for a public takeover bid. It provides a reminder to shareholders about the deadline for accepting the offer and references previously published offer documents. As it is a short announcement (under 5,000 characters of core content, excluding boilerplate) regarding the status of a merger/takeover process, it falls under the M&A Activity category.
2025-10-13 English
M&A Activity 2025
M&A Activity Classification · 100% confidence The document is a corporate announcement (Selskabsmeddelelse) from Bavarian Nordic A/S regarding an ongoing public takeover bid (overtagelsestilbud) by a consortium. It serves as a reminder to shareholders about the expiration of the offer period and provides instructions on how to accept the offer. It is not the offer document itself, but an announcement regarding the status of the transaction and the timeline for shareholders. This fits the definition of M&A Activity (TAR) as it relates to a takeover bid.
2025-10-13 Danish
M&A Activity 2025
M&A Activity Classification · 100% confidence The document is a company announcement regarding a public takeover offer (M&A activity). It specifically serves as a reminder to shareholders about the expiry of the offer period for a tender offer. While it relates to M&A (TAR), the document itself is a formal regulatory announcement issued by the company to inform the market and shareholders of a specific deadline and procedural status, which aligns with the definition of M&A activity announcements.
2025-10-13 English
M&A Activity 2025
M&A Activity Classification · 100% confidence The document is a formal announcement regarding the receipt of regulatory approvals for a public takeover bid (tender offer) for Bavarian Nordic A/S by Innosera ApS. It details the status of the offer, the extension of the offer period, and provides legal disclaimers regarding the transaction. This falls under the category of M&A activity, specifically related to takeover bids and merger proposals.
2025-10-09 Danish
M&A Activity 2025
M&A Activity Classification · 100% confidence The document is an official announcement regarding a public tender offer (takeover bid) for Bavarian Nordic A/S by Innosera ApS. It details the receipt of regulatory approvals, the status of the offer period, and provides information for shareholders regarding the transaction. This falls squarely under M&A activity (takeover bids/merger proposals).
2025-10-09 English
M&A Activity 2025
M&A Activity Classification · 100% confidence The document is a formal corporate announcement regarding the receipt of regulatory approval for a takeover bid (tender offer) for Bavarian Nordic A/S. It details the status of the offer, the remaining conditions, and the timeline for shareholders. This falls under the category of M&A activity (takeover bids/merger proposals).
2025-10-09 Danish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.